Anticoagulation for Cirrhotic Portal Vein Thrombosis: Bold, Brave, and Possibly Beneficial

Clinical Gastroenterology and Hepatology

Volumn 10, Issue 7, 2012, Pages 784-785

  Campbell, Stewart ^a   Lachlan, Neil J ^a  

^a HAIRMYRES HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

LOW MOLECULAR WEIGHT HEPARIN; WARFARIN;

ABDOMINAL PAIN; ANTICOAGULANT THERAPY; BLEEDING; EDITORIAL; FOLLOW UP; HUMAN; INTERNATIONAL NORMALIZED RATIO; INTESTINE INFARCTION; LIVER CIRRHOSIS; PORTAL VEIN THROMBOSIS; PROTHROMBIN TIME; RECURRENT DISEASE; SURVIVAL RATE; TREATMENT DURATION;

ANTICOAGULANTS; FEMALE; HUMANS; LIVER CIRRHOSIS; MALE; PORTAL VEIN; VENOUS THROMBOSIS;

EID: 84862699587     PISSN: 15423565     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cgh.2012.03.015     Document Type: Editorial

References (15)

1. Northup P.G., McMahon M.M., Ruhl A.P., et al. Coagulopathy does not fully protect hospitalized cirrhosis patients from peripheral venous thromboembolism. Am J Gastroenterol 2006, 101:1524-1528.
2. Wu H., Nguyen G.C. Liver cirrhosis is associated with venous thromboembolism among hospitalized patients in a nationwide US study. Clin Gastroenterol Hepatol 2010, 8:800-805.
3. Tripodi A., Mannucci P.M. The coagulopathy of chronic liver disease. N Engl J Med 2011, 365:147-156.
4. Amitrano L., Guardascione M.A., Brancaccio V., et al. Risk factors and clinical presentation of portal vein thrombosis in patients with liver cirrhosis. J Hepatol 2004, 40:736-741.
5. Janssen H.L., Wijnhoud A., Haagsma E.B., et al. Extrahepatic portal vein thrombosis: aetiology and determinants of survival. Gut 2001, 49:720-724.
6. DeLeve L.D., Valla D.C., Garcia-Tsao G. AASLD practice guidelines: vascular disorders of the liver. Hepatology 2009, 49:1729-1764.
7. Okuda K., Ohnishi K., Kimura K., et al. Incidence of portal vein thrombosis in liver cirrhosis: an angiographic study in 708 patients. Gastroenterology 1985, 89:279-286.
8. Francoz C., Belghiti J., Vilgrain V., et al. Splanchnic vein thrombosis in candidates for liver transplantation: usefulness of screening and anticoagulation. Gut 2005, 54:691-697.
9. Qi X., Bai M., Yang Z., et al. Occlusive portal vein thrombosis as a new marker of decompensated cirrhosis. Med Hypotheses 2011, 76:522-526.
10. Wanless I.R., Wong F., Blendis L.M., et al. Hepatic and portal vein thrombosis in cirrhosis: possible role in development of parenchymal extinction and portal hypertension. Hepatology 1995, 21:1238-1247.
11. Tsochatzis E.A., Senzolo M., Germani G., et al. Systematic review: portal vein thrombosis in cirrhosis. Aliment Pharmacol Ther 2010, 31:366-374.
12. Amitrano L., Guardascione M.A., Menchise A., et al. Safety and efficacy of anticoagulation therapy with low molecular weight heparin for portal vein thrombosis in patients with liver cirrhosis. J Clin Gastroenterol 2010, 44:448-451.
13. Delgado M.G., Seijo S., Yepes I., et al. Efficacy and safety of anticoagulation on patients with cirrhosis and portal vein thrombosis. Clin Gastroenterol Hepatol 2012, 10:776-783.
14. Senzolo M., Sartori M.T., Rossetto V., et al. Algorithm for the management of portal vein thrombosis in patients with cirrhosis: a prospective case-control study. Hepatology 2010, 52(Suppl 1):903A.
15. Villa E., Zecchini R., Marietta M., et al. Enoxaparin prevents portal vein thrombosis and decompensation in advanced cirrhotic patients: final report of a prospective randomized controlled study. Hepatology 2011, 54(Suppl 1):418A-419A.